The Global HER2 Antibodies Market was valued $8106.1 Mn in 2020 and is expected to reach $8543.4 Mn by 2026, at a CAGR of 5.0%.
Market Introduction and Overview

Human epidermal growth factor receptor 2 (HER2) plays a central role as a prognostic and predictive marker in breast cancer specimens. It is a trans-membrane tyrosine kinase receptor belonging to the family of epidermal growth factor receptors (EGFRs).

Among all the chronic diseases worldwide cancer is considered to be the most prevalent disease. Approximately 1,685,210 new cancer cases were diagnosed and about 595,690 cancer deaths in the US in year 2016. Whereas around 2,600 men and 246,660 that is about 29% women were diagnosed with breast cancer in year 2016. HER2 breast cancer is one of the aggressive type of breast cancer, caused due to over-expression of the HER2 protein. Breast cancers that overexpress the HER2 protein (known as HER2+) make up about 20% of the cases. HER2 positive breast cancer inclines to grow more rapidly than HER2 negative breast cancer.

The factors such as being overweight, long term heavy smoking, use of menopausal hormone therapy, alcohol consumption, physical inactivity and many more are responsible for increasing risk of breast cancer. Increasing incidence of breast cancer is expected to lead to increase in demand for targeted therapies and boost the growth of the HER2 antibodies market during the forecast period.
Emphasis on standardization of procedures, internal and external quality control assessment affect the market growth positively. Competency evaluation of already existing methods to ensure accurate, reliable, and clinically meaningful test results is helping the market grow upwards. Development of new robust and accurate diagnostic assays by key market players is being encouraged, thereby fuelling the growth. In addition, large clinical trials are warranted to identify the technique that most reliably predicts a positive response to anti-HER2 drugs.

The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the HER2 Antibodies Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

The report has profiled more than fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Global HER2 Antibodies Market Segment Analysis

By Treatment drugs type, Trastuzumab is estimated to account for 62.1% of the HER2 antibodies market share of the total revenue. The monoclonal antibody trastuzumab is the first HER2-targeting drug approved by the FDA, for cancer treatment. By significantly extending the time to disease progression and overall survival of patients, it has become established in all treatment lines of early and metastatic HER2-positive breast cancer. Trastuzumab is a monoclonal antibody, which is one of the best option to treat breast cancer. It is especially used for breast cancer that is human epidermal growth factor receptor 2 (HER2) positive.

Pipeline drugs offer hope for cancer patients, and hence, the healthcare industry has been relying on these drugs to improve the field of oncology. More drugs are in the clinical trials phases and are expected to be approved soon. Increasing cancer prevalence is increasing the demand for new cancer therapeutics from pharmaceuticals, thereby escalating the demand for HER2 antibodies market.
By end-use, the hospital segment is expected to register a CAGR of xx% during the forecast period holding an expected revenue value of $xx Mn in the HER2 antibodies Market. Surgeries and other operations are performed majorly in hospitals, due to availability of all tools and technologies required. Testing procedures conducted in hospitals or hospital-attached outpatient facilities enable ease of handling any emergency situations that may arise. Rapid expansion of hospitals coupled with availability of analysers and consumables based on hospital needs is also expanding the segment.

To know about the Research Methodology :- Request Free Sample Report
Global HER2 Antibodies Market

Regional InsightsNorth America accounted for the largest share of xx% in 2020, reason being the rising prevalence of cancer. Growth in insurance coverage in the U.S. has increased the burden on the country’s healthcare system, which has highlighted the need for improving efficiency and management of work in North America. Well-established healthcare infrastructure, ease of availability is also a key driver affecting the market growth. Investments by key players in this field has boosted the market growth. Rising adoption of technologically advanced diagnostic imaging systems for lymphedema is rapidly growing the market.

Asia Pacific is also expected to witness significant growth during the forecast period due to the increasing geriatric population and rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand.

The report also helps in understanding Global HER2 Antibodies Market dynamics, structure by analysing the market segments and project the Global HER2 Antibodies Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global HER2 Antibodies Market make the report investor’s guide.
Scope of the Global HER2 Antibodies Market: Inquire before Buying

Global HER2 Antibodies Market ,By Region

• North America
• Europe
• South America
• MEA
• Asia Pacific
Key Players Operating in the Global HER2 Antibodies Market

• Pfizer INC
• Genentech INC
• Novartis AG
• Bio-Techne by Novus Biologicals
• Abnova Corporation
• B. Braun Melsungen AG
• Bovie Medical Corporation
• Conmed
• Ethicon Endo-surgery
• Karl Storz
• KLS Martin
• Maxer Endoscopy
• Medical technologies
• Medtronic
• Olympus Corporation
• Abnova
• Invivo Gen
• Biocon
• Celltrion

For More Information Visit @:https://www.maximizemarketresearch.com/market-report/global-her2-an...

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high gr owth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.